Skip to main content
Earnings Labs
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR)

NASDAQ·Healthcare·Biotechnology

$4.28

+1.79%

Mkt Cap $242.65M

Analyst Ratings

Buy

5

Hold

4

Sell

0

Price Target (20 analysts)

$5.83

Range $3.50$7.00

Implied Upside

+36.2%

Consensus $5.83 vs current $4.28